S&P 500 7,568.92 +0.36%
Nasdaq 25,372.01 +0.83%
S&P/TSX 35,532.28 −0.75%
Apple 331.90 −1.90%
Nvidia 206.69 +2.29%
Microsoft 520.99 +2.74%
Shopify 200.19 −8.02%
Royal Bank 285.42 −0.28%
CAD/USD 0.7157 +0.07%
CLOSED · 00:10 ET
Market ClerkRecap
Wed Nov 4 · markets closed3 signals on Nov 3175 insider buys this week · $365.2MCIRO short report next: Nov 14The week ahead
MR
INSIDER · KNSA · Kiniksa Pharmaceuticals International, plc · CHIEF OPERATING OFFICER

Moat Ross

Every open-market transaction filed under this name, Oct 30 to Nov 2.

Filings
11
0 buys · 11 sells
Bought
—
open market, at cost
Sold
$9.6M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell722$94.05$68K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell11,642$93.15$1.1M—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell8,932$92.05$822K—
Nov 2KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell6,681$91.23$610K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell2,575$97.76$252K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell1,760$97.10$171K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell3,672$96.03$353K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell6,282$94.92$596K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell8,430$93.97$792K—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell15,114$92.81$1.4M—
Oct 30KNSAKiniksa Pharmaceuticals International, plcCHIEF OPERATING OFFICERSell37,775$92.00$3.5M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.